Denali Advisors LLC

SEC CIK: 0001142941
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Denali Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overview All 13F holders of KALV Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2022

Holdings of KALV by Denali Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−29,200−100.0%	Sold out	Holders
Q2 2023	29,200	$262.8K	0.1%	+23,400+403.4%	Added	Holders
Q1 2023	5,800	$45.6K	<0.1%	−5,000−46.3%	Reduced	Holders
Q4 2022	10,800	$73.0K	<0.1%	+10,800	New	Holders